{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:59:04Z","timestamp":1790621944950,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jdermsci.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T19:57:52Z","timestamp":1457207872000},"page":"95-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling"],"prefix":"10.1016","volume":"83","author":[{"given":"Fengjun","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.03.003_bib0005","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00018-012-1152-9","article-title":"Cutaneous wound healing: recruiting developmental pathways for regeneration","volume":"70","author":"Bielefeld","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.suc.2014.05.005","article-title":"Biology and principles of scar management and burn reconstruction","volume":"94","author":"Tredget","year":"2014","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.det.2013.11.002","article-title":"New insights on keloids, hypertrophic scars, and striae","volume":"32","author":"Ud-Din","year":"2014","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/exd.12419","article-title":"Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective","author":"van den Broek","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2133.2012.11190.x","article-title":"Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates","volume":"167","author":"Bagabir","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/jcb.22873","article-title":"Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases","volume":"111","author":"Lee","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/scrt111","article-title":"Mesenchymal stem cell therapy for attenuation of scar formation during wound healing","volume":"3","author":"Jackson","year":"2012","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/wrr.12152","article-title":"Application of stems cells in wound healing\u2013an update","volume":"22","author":"Teng","year":"2014","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0045","doi-asserted-by":"crossref","first-page":"340257","DOI":"10.1155\/2014\/340257","article-title":"Management of fibrosis: the mesenchymal stromal cells breakthrough","volume":"2014","author":"Usunier","year":"2014","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0050","first-page":"459","article-title":"Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis","volume":"10","author":"Mohamadnejad","year":"2007","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0055","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","article-title":"Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial","volume":"21","author":"Kharaziha","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"Suppl. 2","key":"10.1016\/j.jdermsci.2016.03.003_bib0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","article-title":"Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients","volume":"27","author":"Zhang","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/SAP.0b013e3181e6d06c","article-title":"Adipose-derived stem cells for wound healing applications","volume":"66","author":"Cherubino","year":"2011","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/scrt417","article-title":"Human Wharton\u2019s jelly mesenchymal stem cells promote skin wound healing through paracrine signaling","volume":"5","author":"Arno","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5966\/sctm.2011-0024","article-title":"Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells","volume":"1","author":"Jackson","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.transproceed.2005.01.070","article-title":"Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries","volume":"37","author":"Mansilla","year":"2005","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0085","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.yexcr.2010.05.009","article-title":"Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair","volume":"316","author":"Hocking","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5966\/sctm.2011-0019","article-title":"Concise review: mesenchymal stem cells and translational medicine: emerging issues","volume":"1","author":"Ren","year":"2012","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/exd.12141","article-title":"Mesenchymal stem cell therapy in skin: why and what for","volume":"22","author":"Khosrotehrani","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0100","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/SAP.0b013e3181e05039","article-title":"Adenovirus-mediated human interleukin 24 (MDA-7\/IL-24) selectively suppresses proliferation and induces apoptosis in keloid fibroblasts","volume":"66","author":"Liang","year":"2011","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0105","doi-asserted-by":"crossref","first-page":"291814","DOI":"10.1155\/2013\/291814","article-title":"An experimental novel study: angelica sinensis prevents epidural fibrosis in laminectomy rats via downregulation of hydroxyproline, IL-6, and TGF- beta 1","volume":"2013","author":"Zhang","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0110","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.bcp.2013.02.038","article-title":"Thalidomide inhibits fibronectin production in TGF-ss1-treated normal and keloid fibroblasts via inhibition of the p38\/Smad3 pathway","author":"Liang","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jcb.24724","article-title":"Human keloid cell characterization and inhibition of growth with human Wharton\u2019s jelly stem cell extracts","volume":"115","author":"Fong","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5966\/sctm.2013-0120","article-title":"Effect of human wharton\u2019s jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts","volume":"3","author":"Arno","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1742-481X.2011.00771.x","article-title":"The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring","volume":"8","author":"Chalmers","year":"2011","journal-title":"Int. Wound J."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0135","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0140","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","article-title":"Transforming growth factor-beta and fibrosis","volume":"13","author":"Verrecchia","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0145","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1172\/JCI43230","article-title":"CTGF directs fibroblast differentiation from human mesenchymal stem\/stromal cells and defines connective tissue healing in a rodent injury model","volume":"120","author":"Lee","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0155","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2353\/ajpath.2008.080272","article-title":"Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts","volume":"173","author":"Tuan","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0160","doi-asserted-by":"crossref","first-page":"e75600","DOI":"10.1371\/journal.pone.0075600","article-title":"Site-Specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling","volume":"8","author":"Ashcroft","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0165","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/exd.12368","article-title":"Treg-enriched CD4+T cells attenuate collagen synthesis in keloid fibroblasts","volume":"23","author":"Murao","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0170","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/TA.0b013e3181c4070d","article-title":"Syndecan-2 and decorin: proteoglycans with a difference\u2013implications in keloid pathogenesis","volume":"68","author":"Mukhopadhyay","year":"2010","journal-title":"J. Trauma"},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0175","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1524-475X.2011.00677.x","article-title":"Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar","volume":"19","author":"Honardoust","year":"2011","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jdermsci.2016.03.003_bib0180","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/TA.0b013e3181c4070d","article-title":"Syndecan-2 and decorin: proteoglycans with a difference\u2013implications in keloid pathogenesis","volume":"68","author":"Mukhopadhyay","year":"2010","journal-title":"J. Trauma"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116300275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116300275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T07:56:36Z","timestamp":1567670196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116300275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0923181116300275"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.03.003","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd on behalf of Japanese Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}